Sánchez AG, Cabrera GJL, Gbenou MY, Francisco DB

Language: Spanish
References: 11
Page: 184-190
PDF size: 122.50 Kb.

ABSTRACT

The fibrosarcoma is the more incident mesodermic malignant neoplasm. Authors present this clinical case presenting with this entity to emphasize on the significance of the appropriate diagnostic and therapeutical management for rehabilitation of these patients. This patient is aged 54 with a history of controlled high blood pressure (HBT) who over the 23 past years begun to show an increase of volume in left genial region thus its surgical intervention in 1987, 1991 and 2009 years and came to consultation presenting with a 5 cm diameter lesion with a fast growth pattern bleeding spontaneously compressing the left ocular globe restricting the palpebral opening. After the corresponding preoperative study authors prescribed the surgical treatment obtaining a conclusive diagnosis according to a immunohistochemical study of the fibrosarcoma of intermediate degree of differentiation with a marked CD34 (+, focal) immunoreactivity, Vimentin (+,focal). We conclude that the treatment of this entity is of surgical type, taking into account the current oncology guidelines and its therapeutical approach must to be multidisciplinary to achieve the functional and aesthetic rehabilitation of the patient. The immunohistochemistry is a conclusive diagnostic tool contributing to apply the appropriate treatment in this type of lesion.

REFERENCES

1. Santana Garay JC. Atlas de Patología del Complejo Bucal. 2da. edición. La Habana: Ed. Ciencias Médicas; 2010.

2. Yamaguchi S, Nagasawa H, Suzuki T, Fujii E. Sarcomas of the oral and maxillofacial region: A review of 32 cases in 25 years. Clin Oral Investig. 2004;8(2):52-5.

3. Barnes L, Evenson JW, Reinchart P, Sindransky D. World Health Organization Classification of Tumors. Lyon: IARC Press; 2005. p. 294-5.

4. Menon AG, Anderson KM, Riccardi VM. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA. 1990;87(6):5435-9.

5. Sarancone S, Acosta G. Inmunohistoquímica en tumores de partes blandas. 2005 [consultado 5 Nov 2010] Disponible en: http://www.patologia.org.ar/eventos/jornadas/2005/haab.html

6. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol. 2007;3(1):1813-24.

7. Angiero, F. Fibrosarcoma of the jaws: two cases of primary tumors with intraosseous growth. Anticancer Res. 2007;27(4c):2573-81.

8. Huguet P, Dinarés C, Iglesias C. Dos casos de sarcoma de partes blandas de presentación insólita, con dificultades para el diagnóstico. Revista Española de Patología. 2009;42(2):33-5.

9. Krygier J, Lewis V. Fibrosarcoma of bone: A review of a rare malignancy of bone. Liddy Shriver Sarcoma Initiative. 2009;6(2):1375-80.

10. Cruz J, Navarro S, Guerra M. Valor de la inmunohistoquímica en la tipificación de los sarcomas de partes blandas y su discordia con el análisis histopatológico convencional: un estudio de casos procedentes del INOR (Cuba). Revista Española de Patología. 2005;38(3):66-77.

11. García J, Hernández C. Aplicación de CD34 en el diagnóstico diferencial de los tumores fusocelulares. Laboratorio de Patología Molecular NOVAPATH, Academia Biomédica Digital. 2008. [consultado 15 Nov 2010]. Disponible en: http://caibco.ucv.ve/caibco/vitae/ vitaeonce/articulos/anatomiapatologica/ archivoshtml/anatopato.pdf